Scientific work

Prof. Dr. Nilüfer Avcı

38 publications. The source of the information is stated next to each publication.

Back to profile

  1. A1. Avci N, Cecener G, Deligonul A, Erturk E, Tunca B, Egeli U, Tezcan G, Akyildiz EU, Bayram AS, Gebitekin C, Kurt E, Evrensel T. Molecular markers for patients with thymic malignancies: not feasible at present? Asian Pac J Cancer Prev. 2014;15(8):3457-60. PubMed PMID: 24870739.

    Source: medicana.com.tr profile page

  2. A2. Ulas A, Kos T, Avci N, Cubukcu E, Olmez OF, Bulut N, Degirmenci M. Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival. Asian Pac J Cancer Prev. 2015;16(4):1643-9. PubMed PMID: 25743846.

    Source: medicana.com.tr profile page

  3. A3. Kanat O, Cubukcu E, Avci N, Budak F, Ercan I, Canhoroz M, Olmez F. Comparison of three different treatment modalities in the management of cancer cachexia. Tumori. 2013 Mar-Apr;99(2):229-33. doi: 10.1700/1283.14197. PubMed PMID: 23748819.

    Source: medicana.com.tr profile page

  4. A4. Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M, Kurt E, Evrensel T. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. J BUON. 2015 Jan-Mar;20(1):45-9. PubMed PMID: 25778295.

    Source: medicana.com.tr profile page

  5. A5. Avci N, Deligonul A, Tolunay S, Cubukcu E, Olmez OF, Altmısdortoglu O, Tanrıverdi O, Kurt E, Evrensel T. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy. J BUON. 2015 Jul-Aug;20(4):994-1000.

    Source: medicana.com.tr profile page

  6. A6. Cubukcu E, Olmez OF, Avci N, Canhoroz M, Kurt E, Kanat O, Evrensel T, Manavoglu O. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors. J BUON. 2012 Jul-Sep;17(3):517-21. PubMed PMID: 23033292.

    Source: medicana.com.tr profile page

  7. A7. Ulas A, Turkoz FP, Silay K, Tokluoglu S, Avci N, Oksuzoglu B, Alkis N. A laboratory prognostic index model for patients with advanced non-small cell lung cancer. PLoS One. 2014 Dec 4;9(12):e114471. doi: 10.1371/journal.pone.0114471. PubMed PMID: 25474743; PMCID: PMC4256446.

    Source: medicana.com.tr profile page

  8. A8. Ulas A, Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. Medication Errors in Chemotherapy Preparation and Administration: a Survey Conducted among Oncology Nurses in Turkey. Asian Pac J Cancer Prev. 2015;16(5):1699-705. PubMed PMID: 25773812.

    Source: medicana.com.tr profile page

  9. A9. Tanriverdi O, Cokmert S, Oktay E, Pilanci KN, Menekse S, Kocar M, Sen CA, Avci N, Akman T, Ordu C, Goksel G, Meydan N. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy. Med Oncol. 2014 Oct;31(10):217. doi: 10.1007/s12032-014-0217-z. PubMed PMID: 25216865.

    Source: medicana.com.tr profile page

  10. A10. Tanriverdi O, Yildirim B, Gul S, Cevik E, Akman T, Cokmert S, Pilanci KN, Avci N, Ordu C, Barutca S. Effect of lower extremity deep vein thrombosis on cancer recurrence in stage III colon cancer patients. Med Oncol. 2014 Oct;31(10):215. doi: 10.1007/s12032-014-0215-1. PubMed PMID: 25208817.

    Source: medicana.com.tr profile page

  11. A11. Tanriverdi O et al. Clinical and pathological features of 133 colorectal cancer patients with brain metastasis: multicenter retrospective analysis. Med Oncol. 2014 Sep;31(9):152. doi: 10.1007/s12032-014-0152-z. PubMed PMID: 25108599.

    Source: medicana.com.tr profile page

  12. A12. Yildiz I et al. Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: Turkish Oncology Group trial. Anticancer Res. 2014 Aug;34(8):4329-34. PubMed PMID: 25075067.

    Source: medicana.com.tr profile page

  13. A13. Canhoroz M et al. Clinical significance of adiponectin expression in colon cancer patients. J Cancer Res Ther. 2014 Apr-Jun;10(2):347-53. doi: 10.4103/0973-1482.136634.

    Source: medicana.com.tr profile page

  14. A14. Cecener G et al. BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients. Cancer Invest. 2014 Oct;32(8):375-87. doi: 10.3109/07357907.2014.919302.

    Source: medicana.com.tr profile page

  15. A15. Cubukcu E et al. Lack of prognostic significance of adiponectin expression in triple-negative breast cancer. Contemp Oncol (Pozn). 2014;18(1):34-8. doi: 10.5114/wo.2014.40454.

    Source: medicana.com.tr profile page

  16. A16. Hartavi M et al. The SOCS-1 -1478CA/del polymorphism is not associated with colorectal cancer in Turkish subjects. Asian Pac J Cancer Prev. 2013;14(12):7583-6.

    Source: medicana.com.tr profile page

  17. A17. Uyeturk U et al. Risk factors for stage IV breast cancer at presentation in Turkey. Asian Pac J Cancer Prev. 2013;14(12):7445-9.

    Source: medicana.com.tr profile page

  18. A18. Olmez OF et al. Prognostic significance of HER-3 expression in metastatic breast cancer. Asian Pac J Cancer Prev. 2013;14(7):4115-9.

    Source: medicana.com.tr profile page

  19. A19. Cubukcu E et al. Prognostic significance of ER, PR, HER2/neu, Ki-67, and nm23 expression in invasive breast cancer. J BUON. 2013 Apr-Jun;18(2):359-65.

    Source: medicana.com.tr profile page

  20. A20. Olmez OF et al. c-Met expression as independent predictor of survival in glioblastoma multiforme. Clin Transl Oncol. 2014 Feb;16(2):173-7.

    Source: medicana.com.tr profile page

  21. A21. Kurt E et al. Evaluation of carboplatin plus docetaxel regimen in elderly advanced gastric cancer patients. J BUON. 2013 Jan-Mar;18(1):147-53.

    Source: medicana.com.tr profile page

  22. A22. Olcun Umit Unal et al. Clinicopathologic characteristics and prognostic factors of primary thoracic soft tissue sarcoma. Thoracic Cancer. 2015;6(1):85–90. doi: 10.1111/1759-7714.12150.

    Source: medicana.com.tr profile page

  23. A23. Kocak N et al. Effects of 1alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations. Acta Oncol. 2004;43(2):204-8.

    Source: medicana.com.tr profile page

  24. A24. Akman T et al. A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solutions. UHOD 2014;3(24):1-7.

    Source: medicana.com.tr profile page

  25. A25. Nilüfer Avcı et al. General Characteristics of Male Breast Cancer Patients in Bursa Region. J Breast Health. 2012;8(3):126-129.

    Source: medicana.com.tr profile page

  26. A26. Nilüfer Avcı et al. Prevalence of Herbal Product Use as Alternative Medicine Among Cancer Patients in Turkey. J Clin Anal Med. 2015;6(3):327-30.

    Source: medicana.com.tr profile page

  27. A27. Nilüfer Avcı et al. Metaplastic Breast Cancer and EGFR Expression. J Clin Anal Med. 2015;6(5):616-9.

    Source: medicana.com.tr profile page

  28. A28. Çubukçu S et al. Efficacy of Sunitinib in Imatinib Resistant GIST Patients. J Clin Anal Med. 2014;5(4):304-6.

    Source: medicana.com.tr profile page

  29. A29. Ordu Ç et al. Prognostic Relevance of Sunitinib Toxicities in Metastatic Renal Cell Cancer. Contemporary Oncology. 2014.

    Source: medicana.com.tr profile page

  30. A30. Tanriverdi O et al. Pretreatment Serum Albumin Level as Prognostic Factor in Stage IIIB NSCLC. Asian Pac J Cancer Prev. 2015;16(14):5971-6.

    Source: medicana.com.tr profile page

  31. A31. Avci N et al. Smoking habits as independent prognostic factor in lung cancer. Clin Respir J. 2015.

    Source: medicana.com.tr profile page

  32. A32. Nayir E et al. Tendency of cancer patients and relatives to use internet for health searches. J BUON. 2016;21(3):714-9.

    Source: medicana.com.tr profile page

  33. A33. Deligonul A et al. HER-4 expression and prognosis in metastatic breast cancer. J BUON. 2016;21(3):564-9.

    Source: medicana.com.tr profile page

  34. A34. Tanriverdi O et al. Mean platelet volume predicting isolated bone metastases in breast cancer. J BUON. 2016;21(4):840-850.

    Source: medicana.com.tr profile page

  35. A35. Avcı N et al. Association and prognostic significance of -1562C/T polymorphism in MMP-9 in gastric cancer. Pathol Oncol Res. 2015;21(4):1243-7.

    Source: medicana.com.tr profile page

  36. A36. Süner A et al. Effectiveness and safety of cabazitaxel chemotherapy in metastatic castration-resistant prostate carcinoma. Eur Rev Med Pharmacol Sci. 2016;20(7):1238-43.

    Source: medicana.com.tr profile page

  37. A37. Artaç M et al. Bevacuzimab effectiveness in obese metastatic colorectal cancer patients. J Gastrointest Cancer. 2018.

    Source: medicana.com.tr profile page

  38. A38. Aksoy A et al. Hormone receptor status and survival in medullary breast cancer patients. Saudi Med J. 2017;38(2):156-162.

    Source: medicana.com.tr profile page